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Abstract The rapid identiﬁcation of genetic markers for
multifactorial diseases from genome-wide association
studies is fuelling interest in investigating the predictive
ability andhealth careutilityofgeneticrisk models.Various
measures are available for the assessment of risk prediction
models, each addressing a different aspect of performance
and utility. We developed PredictABEL, a package in R that
covers descriptive tables, measures and ﬁgures that are used
in the analysis of risk prediction studies such as measures of
model ﬁt, predictive ability and clinical utility, and risk
distributions, calibration plot and the receiver operating
characteristic plot. Tables and ﬁgures are saved as separate
ﬁles in a user-speciﬁed format, which include publication-
quality EPS and TIFF formats. All ﬁgures are available in a
ready-made layout, but they can be customized to the pref-
erences of the user. The package has been developed for the
analysis of genetic risk prediction studies, but can also be
used for studies that only include non-genetic risk factors.
PredictABELisfreelyavailableatthewebsitesofGenABEL
(http://www.genabel.org) and CRAN (http://cran.r-project.
org/).
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Abbreviations
AUC Area under the ROC curve
IDI Integrated discrimination improvement
NRI Net reclassiﬁcation improvement
ROC Receiver operating characteristic
Introduction
The rapid identiﬁcation of genetic markers for multifac-
torial diseases from genome-wide association studies is
fuelling interest in investigating the predictive ability and
health care utility of genetic risk models. Genetic risk
models are investigated for their potential to target diag-
nostic, preventive and therapeutic interventions for multi-
factorial diseases. Implementation of these models in
health care requires a series of studies that encompass all
phases of translational research [1, 2], starting with a
comprehensive evaluation of genetic risk prediction.
Various measures are available for the assessment of
risk prediction models, each addressing a different aspect
of performance and utility [3, 4]. The GRIPS Statement
recommends that transparent and complete reporting
should provide a description of the risk factors and the risk
model by reporting univariate and multivariate odds ratios
for the predictors, present risk distributions for individuals
with and without the outcome of interest, and report
measures of model ﬁt, predictive ability and others, if
pertinent [5, 6]. Examples of measures include the Hos-
mer–Lemeshow statistic [7] and Nagelkerke’s R
2 [8] for
model ﬁt, the area under the receiver operating character-
istic (ROC) curve (AUC) [9] and integrated discrimination
improvement (IDI) [10] for predictive ability, and per-
centages of total reclassiﬁcation [11] and net reclassiﬁca-
tion improvement (NRI) [10] for clinical utility.
Even though the assessment of risk prediction models is
relatively standard, there is no single statistical package
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these measures and plots. Therefore, we developed Pre-
dictABEL, a freely available R package, which contains
functions to obtain all descriptive tables, measures and
plots that are used in genetic risk prediction studies.
Description of PredictABEL
The core part of PredictABEL comprises functions for the
assessment of risk prediction models. The measures and
plots covered in PredictABEL are listed in Table 1. Most
functions can be applied to predicted risks, risk scores or
any other continuous predictor variable, but some to pre-
dicted risks (probabilities) only. Predicted risks and genetic
risk scores can be obtained using functions in the package,
but they can be imported from other programs as well. The
functions to obtain predicted risks using logistic regression
analysis are speciﬁcally written for models that include
genetic variables, eventually in addition to non-genetic
factors, but they can also be applied to construct models
based on non-genetic risk factors only. Genetic risk scores
can be computed as unweighted and weighted risk scores,
where weights are obtained from uploaded data or impor-
ted from meta-analyses, e.g., as beta coeffcients.
The tables and plots generated using PredictABEL are
saved as separate ﬁles in the working directory. Tables can
be saved as Excel or tab-delimited text ﬁles and ﬁgures can
be saved as publication-quality EPS or TIFF ﬁles or as
JPEG ﬁles for insertion in manuscripts. All ﬁgures are
available in a ready-made layout, but they can be cus-
tomized to the journal style or preferences of the user. A
hypothetical dataset and examples of use are included in
the package to demonstrate all functions.
Example
The hypothetical dataset included in the package was
reconstructed from an empirical study on age-related
macular degeneration (AMD) [12], using a simulation
method that has been described in detail elsewhere [13].
Based on published frequencies and odds ratios of the
genetic variants and non-genetic risk factors implicated in
AMD and on published population disease risks, we cre-
ated a dataset that contains genotype data and disease status
for 10,000 individuals. Predicted risks were obtained using
logistic regression analysis, for which the codes are pro-
vided in the package. Two risk models were constructed: a
model based on non-genetic risk factors only and a model
based on genetic and non-genetic predictors.
Figure 1 presents three examples of plots that are pro-
duced by PredictABEL. Figure 1a shows distributions of
predicted risks based on genetic and non-genetic factors for
individuals with and without AMD. The degree of overlap
between the two histograms is indicative for the
Table 1 Measures and plots covered in PredictABEL (version 1.1)
Measures and plots Description
Description of the data Frequencies
Univariate odds ratios
Allele and genotype frequencies by disease status
Odds ratios per allele and per genotype
Description of the model Multivariate odds ratios
Risk distribution
Predictiveness curve
Odds ratios adjusted for all predictors in the logistic regression model
a
Histogram of predicted risks by disease status






Percentage of variance in the outcome explained by predictors in the logistic
regression model
a
Average squared difference between predicted risks and observed disease status
Calibration Hosmer–Lemeshow statistic
Calibration plot
Average difference between observed and predicted risks across subgroups
Observed and predicted risks across subgroups
Discrimination Receiver operating
characteristic (ROC) curve





Sensitivity and speciﬁcity for all possible cut-off values of predicted risks
Measure of discriminative accuracy
Box plot of predicted risks by disease status
Comparison of mean difference in predicted risks of individuals with and without




Number of individuals per risk category of the initial against the updated model by
disease status
Net improvement in risk classiﬁcation in individuals with and without the disease.
a These functions can only be used when the logistic regression model is constructed using the functions in PredictABEL
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123discriminative accuracy of the risk model. This discrimina-
tive accuracy is assessed by the AUC and visualized in a
ROC plot. Figure 1b presents the ROC curves for the two
risk models. The ﬁgure shows that the model with genetic
factors had a higher AUC than the model without. Using the
same function, the AUC values were quantiﬁed as 0.80 and
0.74.Finally,Fig. 1cpresentsthecalibrationplotfortherisk
model based on the genetic and non-genetic variables as
predictors, which shows how well predicted risks match
observed risks. The calibration plot suggests that the model
was well calibrated, which was supported by the non-sig-
niﬁcance of the Hosmer–Lemeshow test (P = 0.65).
Finally, Table 2 presents an example of the reclassiﬁ-
cation table and statistics that are produced by PredictA-
BEL. The reclassiﬁcation table presents the categorization
into risk groups according to the initial and updated risk
models. The table provides information about the total
number of individuals that change between risk categories
and about correct and incorrect reclassiﬁcation. The per-
centage of total reclassiﬁcation and NRI are calculated
from the reclassiﬁcation table. The table indicates that net
8.8% of the individuals without AMD and 9.6% of those
with AMD would be correctly reclassiﬁed when the clini-
cal model was updated by the addition of genetic factors.
Conclusions
PredictABEL is a comprehensive software package,
designed for the development and assessment of genetic
risk prediction models. PredictABEL is a part of the
GenABEL software suite for statistical genomics [14, 15]
and for that reason written in R to enable easy transfer of
data from gene discovery to genetic prediction studies. A
detailed manual is available that demonstrates and explains
all the functions in the package. The manual is accessible
for researchers who do not regularly use R software. The
manual and the package are freely available from the
GenABEL project website (http://www.genabel.org) and
from CRAN (http://cran.r-project.org/).
Fig. 1 Example graphs produced by PredictABEL. a Distributions of
predicted risks in individuals with and without age-related macular
degeneration (AMD); b ROC plot presenting risk models without and
with genetic variants; and c Calibration plot comparing predicted
risks with observed risks. Figure 1a and c present the risk model
based on genetic and non-genetic risk factors
Table 2 Reclassiﬁcation table comparing clinical risk models without and with genetic factors
Without genetic predictors With genetic predictors Reclassiﬁed Net correctly reclassiﬁed (%)
\10% 10–35% [35% Increased risk Decreased risk
Individuals without AMD
\5% 2,187 459 0
10–35% 1,225 2,913 357 816 1,520 8.8
[35% 15 280 577
Individuals with AMD
\5% 53 34 0
10–35% 93 919 326 360 170 9.6
[35% 1 76 485
Net reclassiﬁcation improvement 18.4% (95% CI 15.8–20.9); P\0.001
AMD age-related macular degeneration, CI conﬁdence interval. Values are numbers unless otherwise indicated. The cut-off risk thresholds
chosen are for illustration purposes only and do not reﬂect clinically signiﬁcant categories
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includes all basic descriptive tables, measures and plots
that are used in the assessment of risk prediction models.
Planned extensions of the package include other strategies
to construct risk models, e.g., using Cox Proportional
Hazards analysis for prospective data, and functions to
construct simulated data for the evaluation of genetic risk
models [13]. Furthermore, we will optimize the intercon-
nectivity between PredictABEL and other packages in the
GenABEL suite.
Where the GRIPS Statement aims to improve the
transparency, quality and completeness of reporting [5, 6],
PredictABEL has similar goals for the assessment of
genetic risk prediction studies. The collection of all mea-
sures and plots in a single, software package gives a
comprehensive overview of the various measures that are
available for the assessment of risk prediction studies. This
overview emphasizes that different measures are available
to answer different questions in the assessment of risk
models and facilitates the selection of the most appropriate
measure for the question under study.
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